Mounjaro® Side Effects UK — What to Expect and How to Manage Them
Mounjaro® (tirzepatide) is currently one of the most prescribed weight loss medications in the UK private sector. If you’re considering it — or already taking it and experiencing side effects — this guide covers everything you need to know, based on the SURMOUNT-1 clinical trial data published in the New England Journal of Medicine (2022).
Mounjaro® Side Effects — How Common Are They?
| Side Effect | Frequency (15mg dose) | Frequency (2.5mg starting dose) |
|---|---|---|
| Nausea | 44% | 12% |
| Diarrhoea | 30% | 14% |
| Decreased appetite | 25% | 10% |
| Vomiting | 22% | 6% |
| Constipation | 17% | 10% |
| Abdominal pain | 10% | 6% |
| Injection site reaction | 5% | 4% |
| Dyspepsia | 9% | 4% |
How to Manage the Most Common Mounjaro® Side Effects
Nausea (most common)
- Eat smaller, more frequent meals — avoid large portions
- Avoid high-fat, greasy or spicy food, especially on injection day
- Inject at bedtime to sleep through peak effect
- Stay hydrated — dehydration worsens nausea
- If severe after dose increase, return to previous dose for an extra 4 weeks
Diarrhoea
- Increase fluid intake to prevent dehydration
- Temporarily reduce fibre intake
- Avoid alcohol — it significantly worsens GI side effects
- OTC loperamide (Imodium) can provide relief for acute episodes
Constipation
- Increase water intake to at least 2.5 litres daily
- Increase dietary fibre gradually
- Light exercise (walking) stimulates bowel motility
- Osmotic laxatives (Movicol) can help if needed
Serious Mounjaro® Side Effects — When to Stop and Seek Help
- Severe, persistent abdominal pain (may indicate pancreatitis — stop immediately, seek emergency care)
- Significant vision changes (diabetic retinopathy risk with rapid glucose changes)
- Persistent vomiting preventing adequate fluid intake (dehydration)
- Symptoms of gallbladder disease — upper right abdominal pain, nausea, fever
- Allergic reaction — rash, facial swelling, difficulty breathing
Mounjaro® carries a black box warning regarding thyroid C-cell tumours based on rodent studies. It is contraindicated in patients with personal or family history of medullary thyroid carcinoma or MEN 2. See the full FDA prescribing information: Mounjaro® NDA 215866 →
Mounjaro® Is Too Expensive — What Are the Alternatives?
Mounjaro® costs £1,050–£1,400/month on private prescription in the UK. For many patients, this is simply not sustainable long-term. The good news: the identical active molecule (tirzepatide) is available as a compounded alternative at significantly lower cost.
Compounded Tirzepatide UK — Same Molecule, 80% Less
Our compounded tirzepatide uses the same dual GLP-1/GIP active ingredient as Mounjaro® — compounded to ≥98% purity at a PCAB-accredited pharmacy. Every order includes physician review, personalised dosing protocol and 48hr UK delivery:
- Compounded Tirzepatide 20mg UK — from £199/month
- Compounded Tirzepatide 40mg UK — from £249/month
- Revion Tirzepatide 20mg UK — £199/month
Or Consider Retatrutide — Even Stronger Results
If you’re already considering tirzepatide, retatrutide UK is worth considering — it’s the next step up in efficacy (24.2% vs 22.5% weight loss) for £100/month more than our tirzepatide options. Many buyers who have tried Mounjaro® find retatrutide produces noticeably stronger results.
Questions? WhatsApp our team →